Sunshine Biopharma SBFM Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$9.4MMiss by $1.7M
EPS-$0.39Miss by $0.28
Revenue estimate$11.1M
EPS estimate-$0.11
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$8.7M
EPS estimate-$1.20
Versus estimates
Revenue
Diluted EPS
Ask the moment Sunshine Biopharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Sunshine Biopharma report Q2 2025 earnings?
- Sunshine Biopharma (SBFM) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Sunshine Biopharma's Q2 2025 revenue and EPS?
- Sunshine Biopharma reported revenue of $9.4M and eps of $-0.39 for Q2 2025.
- Did Sunshine Biopharma beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $11.1M by $1.7M. EPS missed the consensus estimate of $-0.11 by $0.28.
- How did Sunshine Biopharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 1.2% from $9.3M a year earlier and eps grew 96.1% from $-9.94.
- Where can I find Sunshine Biopharma's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-005981) directly on SEC EDGAR. The filing index links above go to sec.gov.